Search Results - "Vasile Cioban, Cosmin"
-
1
Partnering bevacizumab with irinotecan as first line-therapy of metastatic colorectal cancer improves progression free survival-A retrospective analysis
Published in PloS one (28-04-2021)“…Colorectal cancer remains one of the most frequent malignancies (third place at both genders) worldwide in the last decade, owing to significant changes in…”
Get full text
Journal Article -
2
The use of autofluorescence for screening and early detection of oral potentially malignant disorders – A narrative review
Published in Revista română de stomatologie (Bucharest, Romania : 2004) (31-12-2022)“…Premalignant lesions of the oral cavity encompass a broad range of pathology and are often comorbid in a variety of patient populations. Prompt diagnosis and…”
Get full text
Journal Article -
3
Doubling the Dose of Bevacizumab Beyond Progression in Metastatic Colorectal Cancer-the Experience of a Tertiary Cancer Center
Published in Frontiers in pharmacology (11-03-2021)“…Colorectal cancer (CRC) is the third most common cancer in Europe, with an annual increase in incidence ranging between 0.4 and 3.6% in various countries…”
Get full text
Journal Article -
4
Treatment beyond progression in metastatic colorectal cancer: to double or not to double the dose of bevacizumab?
Published in Journal of B.U.ON. : official journal of the Balkan Union of Oncology (01-03-2020)“…Bevacizumab or cetuximab represent the standard treatment in association with classical chemotherapy in confirmed metastatic colorectal cancer (mCRC)…”
Get more information
Journal Article -
5
The impact of two-socket preservation approaches on the soft and hard tissue healing: a short-term study in dogs
Published in Romanian journal of morphology and embryology (2015)“…The present study was designed in the context of the uncertain circumstances related to the best therapeutic option for ridge preservation. The research aimed…”
Get full text
Journal Article